Page last updated: 2024-08-05 11:49:02

aminoglycoside

null

ChEBI ID: 47779

Members (21)

MemberDefinitionRole
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[[(2R,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-2-oxanyl]oxy]-14-ethyl-7,12,13-trihydroxy-4-[[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-2-oxanyl]oxy]-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[[(2R,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-2-oxanyl]oxy]-14-ethyl-7,12,13-trihydroxy-4-[[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-2-oxanyl]oxy]-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
(7R,13S)-6-[(2S)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(4R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one(7R,13S)-6-[(2S)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(4R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
14-hydroxyclarithromycin14-hydroxyclarithromycin
aclacinomycinAn anthracycline that is aklavinone having an alpha-L-rhodosaminyl residue attached at position 4 via a glycosidic linkage.aclacinomycin T zwitterion; aclacinomycin T
aclarubicinAn anthracycline antibiotic that is produced by Streptomyces galilaeus and also has potent antineoplastic activity.aclacinomycin A zwitterion; aclacinomycin A
adriamycinolA member of the class of tetracenequinones that is the major metabolite of the anthracycline doxorubicin, a chemotherapeutic agent effective against a broad range of malignant neoplasms. It is thought to exhibit cardiotoxic properties.doxorubicinol
amikacinAn amino cyclitol glycoside that is kanamycin A acylated at the N-1 position by a 4-amino-2-hydroxybutyryl group.amikacin
apramycinAn aminoglycoside that is 2-deoxystreptamine that is substituted on the oxygen at position 4 by an (8R)-2-amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl) group.apramycin
arbekacinA kanamycin that is kanamycin B bearing an N-(2S)-4-amino-2-hydroxybutyryl group on the aminocyclitol ring.arbekacin
davercindavercin
em 201Erythromycin a enol ether
epirubicinAn anthracycline that is the 4'-epi-isomer of doxorubicin.4'-epidoxorubicin
erythromycin 2'-acetateerythromycin acistrate
erythromycin stearateErythromycin stearate
framycetinA tetracyclic antibacterial agent derived from neomycin, being a glycoside ester of neamine and neobiosamine B.framycetin
micronomicinGentamicin C2b
neamine2-Deoxy-D-streptamine glycosylated at the 4-oxygen with a 6-amino-alpha-D-glucosaminyl group.neamine
neomycin cA tetracyclic antibacterial agent derived from neomycin, being a glycoside ester of neamine and neobiosamine C.neomycin C
paromamineAn aminoglycoside that is 4alpha,6alpha-diaminocyclohexane-1beta,2alpha,3beta-triol in which the pro-R hydroxy group has been converted into its 2-amino-alpha-D-glucoside derivative.paromamine
sf-2052Formimidoyl-fortimicin A
tulathromycinTulathromycin A

Research

Studies (18,702)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19907,288 (38.97)18.7374
1990's3,625 (19.38)18.2507
2000's3,530 (18.87)29.6817
2010's3,356 (17.94)24.3611
2020's903 (4.83)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials3,042 (14.80%)5.53%
Reviews806 (3.92%)6.00%
Case Studies1,598 (7.78%)4.05%
Observational65 (0.32%)0.25%
Other15,038 (73.18%)84.16%